METHODS: Of 490 patients with upper urinary tract carcinoma, we retrospectively reviewed the post-treatment course of 58 patients with upper urinary tract CIS who underwent either RNU (RNU group) or BCG therapy (BCG group). Efficacy and safety were compared between the RNU and BCG groups. Inverse probability treatmentweighted (IPTW)-adjusted multivariate Cox regression analysis was performed to identify the influence of BCG therapy on prognosis.
INTRODUCTION AND OBJECTIVES:
The clinical indication of laparoscopic radical nephroureterectomy (LRNU) for locally advanced upper tract urothelial carcinoma (UTUC) patients remain controversial. Our specific aim is to examine whether LRNU could have the same oncological outcome as that of open radical nephroureterectomy (ORNU) for both clinical and pathological T3N0M0 UTUC patients in a propensity adjusted cohort using a multi-institutional collaboration dataset.
METHODS: Among the 670 UTUC patients who underwent RNU from 1990 to 2015, we identified 376 pT3N0M0 UTUC patients as cohort 1. Of the 405 UTUC patients who underwent RNU and were preoperatively evaluated by CT urography from 2005 to 2015, we identified 143 cT3N0M0 UTUC patients as cohort 2. We adopted a propensity score (PS) matching method to both cohorts so as to achieve uniform homogeneity with respect to patient background. PS matching-adjusted Cox-regression analysis was performed to evaluate the impact of surgical modality on oncological outcomes. RESULTS: After PS matching, no significant differences were observed among the patient backgrounds between the LRNU and ORNU patients in each cohort. In cohort 1, the 5-year cancer-specific survival (CSS) was 42.4% in the LRNU group, which was significantly lower than the ORNU group (57.6%, p[0.047) (Figure 1a IVR. In cohort 2, the 5-year CSS was 44.8% in the LNU group, which was significantly lower than the 60.0% in the ONU group (p[0.049) (Figure 1b) . Similar to the result for cohort 1, multivariate Cox regression analysis showed that LRNU remained as one of the independent factors for both poor CSS and developing IVR.
CONCLUSIONS: From both pathological and clinical settings, our study has demonstrated that LRNU may have poorer long-term oncological outcomes than ORNU in T3N0M0 UTUC patients whose potential baseline differences were adjusted by PS matching.
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INTRODUCTION AND OBJECTIVES:
In patients with Ta-3N0M0 upper tract urothelial carcinoma (UTUC) with a longer survival rate as compared to those with T4 and/or NþM0 UTUC, there is an ongoing debate with respect to the key risk factors which influence intravesical recurrence (IVR) after radical nephroureterectomy (RNU). Since conditional survival (CS) analysis provides better estimates of survival time at each follow-up time, we aimed to assess the changes in conditional IVR free rates after RNU and how the impact of wellknown risk factors evolves over time, especially in Ta-3N0M0 UTUC patients.
METHODS: We identified 682 patients with Ta-3N0M0 UTUC who underwent open or laparoscopic RNU from 1980 to 2015 at our 7 institutions. The CS was estimated using the multiplicative law of probability, illustrating IVR free survival with multiple Kaplan-Meier methods. The changing impact of parameters on IVR over time was assessed by multivariate Cox regression analysis.
RESULTS: Median age was 71 years and median follow-up period was 48.4 months. Intravesical recurrence after RNU was detected in 295 patients (43.3%). Five-year IVR free survival (IVRFS) rates after surgery were 44.2% at baseline, but when we assessed the conditional IVRFS probability of surviving a certain number of years after RNU, the 5-year conditional IVRFS rate increased from 44.2% to 59.3%, 71.5%, 77.0% and 94.0% based on 1-, 2-, 3-, and 4-year survivorships (Figure left) . Multivariate analysis revealed that pT2 or lower stage, previous history of a bladder tumor, and laparoscopic RNU were independent risk factors for developing IVR at baseline. We found that the effects of well-known predictive factors lost their statistical significance with time. However, the impact of laparoscopic RNU sustained their statistical power over time. We further demonstrated 5-year conditional probability of IVRFS as a function of prediction time. The probability of an additional 5-year IVR free survivorship (5|s) with open RNU gradually increases after surgery over time (47.9% at s[0 (baseline) to 95.9% at s[5),
